These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7245819)

  • 1. [Compartment analysis in the diagnosis of iron metabolism disorders].
    Konrad H; Neumann J; Esther G; Kiencke H
    Z Gesamte Inn Med; 1981 Mar; 36(5):271-2. PubMed ID: 7245819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ferrokinetic studies in the initial evaluation of idiopathic myelofibrosis: results in 18 patients].
    Escoda L; Cervantes F; Pereira A; López-Guillermo A; Piera C; Rozman C
    Med Clin (Barc); 1992 Sep; 99(9):321-3. PubMed ID: 1434997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbances of iron metabolism in chronic liver diseases.
    Sikorska K; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Stolarczyk J
    Med Sci Monit; 2003 Aug; 9 Suppl 3():64-7. PubMed ID: 15156616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial iron deposits in idiopathic myelofibrosis. Analysis of 20 patients].
    Cervantes F; López-Guillermo A; Piera C; Pereira A; Aguilar JL; Ordi J; Rozman C
    Sangre (Barc); 1993 Aug; 38(4):279-82. PubMed ID: 8235941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron kinetics.
    Szur L; Lewis SM
    Clin Haematol; 1975 Jun; 4(2):407-25. PubMed ID: 1102195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Classification of myelosclerosis according to ferrokinetic investigations].
    Neumann E
    Acta Haematol; 1976; 56(2):89-96. PubMed ID: 823761
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of iron kinetics using a linear scanner. I. Distribution of sites of uptake of plasma iron in hematological disorders.
    Alfrey CP; Lynch EC; Hettig RA
    J Lab Clin Med; 1969 Mar; 73(3):405-17. PubMed ID: 5766186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteomyelofibrosis. Studies of iron and erythrocyte kinetics with radioactive iron and chromium].
    Brunner HE
    Acta Haematol; 1965 Nov; 34(5):257-76. PubMed ID: 4955520
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron metabolism in liver disease.
    Brodanová M; Hoenig V
    Rev Czech Med; 1968; 14(1):1-14. PubMed ID: 5655691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Murine iron metabolism studies using a whole body counter method].
    Deseö G; Csaba B; Nagy G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(4):337-44. PubMed ID: 4127128
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Casalgrandi G; Burani A; Gallo E
    Hepatology; 1993 Jun; 17(6):997-1002. PubMed ID: 8514272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between RBC ferritin content in chronic liver diseases and iron deposition in hepatocytes].
    Mae H
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1244-51. PubMed ID: 7868062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of iron metabolism and Dupuytren's disease.
    Hnanicek J; Cimburova M; Putova I; Svoboda S; Stritesky J; Kratka K; Sosna B; Horak J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):476-80. PubMed ID: 18194242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron in NASH, chronic liver diseases and HCC: how much iron is too much?
    Pietrangelo A
    J Hepatol; 2009 Feb; 50(2):249-51. PubMed ID: 19070915
    [No Abstract]   [Full Text] [Related]  

  • 16. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron and manganese homeostasis in chronic liver disease: relationship to pallidal T1-weighted magnetic resonance signal hyperintensity.
    Malecki EA; Devenyi AG; Barron TF; Mosher TJ; Eslinger P; Flaherty-Craig CV; Rossaro L
    Neurotoxicology; 1999 Aug; 20(4):647-52. PubMed ID: 10499363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders.
    Juncà J; Fernández-Avilés F; Oriol A; Navarro JT; Millá F; Sancho JM; Feliu E
    Haematologica; 1998 Aug; 83(8):676-80. PubMed ID: 9793248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
    Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
    Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.